Nonsteroidal anti-inflammatory drugs contribute to the elevated risk for…
medscape.com
rheumatologynetwork.com
rheumnow.com
Initial results reported by Pfizer and Lilly for two subcutaneous injections with tanezumab showed significant 16-week benefits for osteoarthritis.
mdedge.com
